publication venue for
- Preparation and characterization of dicarboxylic acids salt of aripiprazole with enhanced physicochemical properties.. 26:455-463. 2021
- Tulsi oil as a potential penetration enhancer for celecoxib transdermal gel formulations.. 19:21-30. 2014
- Strategies of targeting oral drug delivery systems to the colon and their potential use for the treatment of colorectal cancer.. 17:521-540. 2012
- Physicochemical and mechanical properties of carbamazepine cocrystals with saccharin.. 17:457-465. 2012
- Quality by design in formulation and process development for a freeze-dried, small molecule parenteral product: a case study.. 16:549-576. 2011
- In vitro release, rheological, and stability studies of mefenamic acid coprecipitates in topical formulations.. 16:497-510. 2011
- Complexation of risperidone with a taste-masking resin: novel application of near infra-red and chemical imaging to evaluate complexes.. 14:409-421. 2009
- Optimization and in vivo evaluation of an oral dual controlled-release tablet dosage form of insulin and duck ovomucoid.. 13:291-298. 2008
- Controlled release multiparticulate beads coated with starch acetate: material characterization, and identification of critical formulation and process variables.. 12:307-320. 2007
- Response surface methodology to obtain beta-estradiol biodegradable microspheres for long-term therapy of osteoporosis.. 11:377-387. 2006
- Transdermal delivery of flurbiprofen: permeation enhancement, design, pharmacokinetic, and pharmacodynamic studies in albino rats.. 10:343-351. 2005
- Response surface methodology for the development of self-nanoemulsified drug delivery system (SNEDDS) of all-trans-retinol acetate.. 10:363-370. 2005
- Salbutamol sulfate suppositories: influence of formulation on physical parameters and stability.. 8:21-30. 2003
- Permeability of chemical delivery systems across rabbit corneal (SIRC) cell line and isolated corneas: a comparative study.. 5:409-416. 2000
- Chemical delivery systems: evaluation of physicochemical properties and enzymatic stability of phenylephrone derivatives.. 4:189-198. 1999
- Aqueous-based polymeric dispersion: face-centered cubic design for the development of atenolol gastrointestinal therapeutic system.. 3:423-432. 1998